# Regulating polysaccharide structure and bioactivity via free radical degradation: a review of mechanisms, effects, and application prospects

**Authors:** Jieming Li, Shuaiyi Lv, Yulong Hu, Yuanfang Kong, Juntao Cai, Guanglei Nan, Shiqing Jiang, Shaohua Yang, Chunhong Dong

PMC · DOI: 10.3389/fnut.2026.1725700 · Frontiers in Nutrition · 2026-02-13

## TL;DR

This paper reviews how free radical degradation can modify the structure of natural polysaccharides to enhance their health benefits, such as antioxidant and immune-boosting effects.

## Contribution

The paper introduces a systematic review of free radical degradation mechanisms and their impact on polysaccharide structure-activity relationships, offering new insights for functional polysaccharide preparation.

## Key findings

- Free radical degradation improves polysaccharide bioactivity by altering molecular weight and functional groups.
- Optimal bioactivity is achieved with a molecular weight range of 10–1,000 kDa.
- Hydroxyl radical mechanisms and three-stage degradation models are key to understanding structural changes.

## Abstract

Natural polysaccharides from food sources (e.g., ginseng, seaweed, apricot, larch) have diverse bioactivities (antioxidant, immunomodulatory, hypoglycemic) that are closely related to human nutritional health, but their structural heterogeneity (e.g., molecular weight, monosaccharide composition) impedes clear structure-activity relationship (SAR) establishment. Free radical degradation, a mild method preserving labile groups (e.g., sulfate esters), is an effective solution. This review summarizes its role in regulating polysaccharide SAR: focusing on hydroxyl radical (⋅OH)-mediated mechanisms (via Fenton-like reactions: processes that generate hydroxyl radicals through the reaction of H2O2 with metal ions/ascorbic acid), a three-stage kinetic model (rapid depolymerization, main chain scission, slow degradation), and site-specific modifications. Key structural changes (molecular weight reduction, functional group exposure/transformation, monosaccharide composition alteration, conformational shifts) are analyzed, and their synergistic enhancement of bioactivities (antioxidant, immunomodulatory, etc.) is elaborated. Such as, reduced molecular weight improves solubility, while exposed sulfate groups strengthen target binding. The optimal molecular weight range (10–1,000 kDa) and its dependence on polysaccharide sources/activity types are identified. Current challenges (degradation controllability, product characterization) and future directions (advanced techniques like High Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS), Nuclear magnetic resonance (NMR), smart degradation systems) are discussed. This review provides guidance for precise preparation of functional polysaccharides.

## Linked entities

- **Chemicals:** H2O2 (PubChem CID 784), ascorbic acid (PubChem CID 9888239)

## Full-text entities

- **Genes:** F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** type 2 diabetes (MESH:D003924), toxicity (MESH:D064420), CD (MESH:D003424), hypoglycemic (MESH:C000721848), obese (MESH:D009765), cancer (MESH:D009369), hyperlipidemia (MESH:D006949)
- **Chemicals:** porphyran (MESH:C038549), Mn (MESH:D008345), Glucose (MESH:D005947), Fucose (MESH:D005643), hydrogen (MESH:D006859), heparin (MESH:D006493), arabinose (MESH:D001089), Xylose (MESH:D014994), lipid (MESH:D008055), lactones (MESH:D007783), RG-I (MESH:C042491), Fructose (MESH:D005632), Galacturonic Acid (MESH:C007819), Arabinogalactan (MESH:C005653), beta-(1 6) glucan (MESH:C064197), rhamnose (MESH:D012210), Glucuronic Acid (MESH:D020723), sodium (MESH:D012964), oligosaccharide (MESH:D009844), H2O2 (MESH:D006861), -OSO3- (-), Aldehyde (MESH:D000447), Galactose (MESH:D005690), Hydroxyl radicals (MESH:D017665), 13C (MESH:C000615229), CHO (MESH:C034482), ascorbic acid (MESH:D001205), Gal (MESH:C101993), homogalacturonan (MESH:C003181), water (MESH:D014867), cholic acid (MESH:D019826), monosaccharide (MESH:D009005), uronic acid (MESH:D014574), NS (MESH:D009584), pectin (MESH:D010368), Polysaccharides (MESH:D011134), GalA (MESH:C066951), sulfate (MESH:D013431), sugar (MESH:D000073893), Mannose (MESH:D008358), galactan (MESH:D005685), fat (MESH:D005223), metal (MESH:D008670)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Sargassum fusiforme (species) [taxon 590727], Panax ginseng (Asiatic ginseng, species) [taxon 4054], Gracilariopsis lemaneiformis (species) [taxon 2782], Pleurotus tuber-regium (species) [taxon 716892], Prunus armeniaca (apricot, species) [taxon 36596], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** 95D — Homo sapiens (Human), Lung giant cell carcinoma, Cancer cell line (CVCL_7110), SGC-7901 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0520)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945790/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12945790/full.md

## References

109 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945790/full.md

---
Source: https://tomesphere.com/paper/PMC12945790